View Cart (0 items)

Processing e-News

Teva gets approval for generic version of pain reliever Celebrex

The U.S. Food and Drug Administration (FDA) has approved the first generic versions of pain relieving drug product Celebrex (celecoxib).
Read More

Investigation into Williams Partners' safety practices causes alarm

Following a series of violations detected, the U.S. Pipeline and Hazardous Materials Safety Administration has started a federal investigation into the company's safety practices.
Read More

Chemical Safety Board releases new evidence on Deepwater Horizon explosion

The U.S. Chemical Safety Board has published a new report on the cause of the Deepwater Horizon rig oil spill in 2010, which killed 11 people and seriously injured 17 others.
Read More

Louisiana governor restricts lawsuits against oil, gas companies

The bill will result in a "fair and more predictable legal environment" and will support businesses and job creation in Louisiana, Gov. Jindal said.
Read More

US, Canadian authorities recall chia seed powder after Salmonella outbreak

The Canadian Food Inspection Agency (FIA) has announced a recall of a range of products containing sprouted chia seed powder over concerns about a possible Salmonella contamination.
Read More

Keystone XL might be exposed to malicious actions, report warns

Once constructed, TransCanada's proposed Keystone XL oil pipeline could be at risk of attacks that might threaten water supplies to a large number of households, according to a new report.
Read More

Kuwait plans to expand petrochemical operations

Kuwait is set to shift its focus onto petrochemical production and develop the industry to an extent that it accounts to 50 percent of the country's income generated from sectors other than oil.
Read More

Ultrasonic flowmeter market exceeds $600 million worldwide, studies find

According to a recent series of studies from Flow Research, the market for ultrasonic meters totaled $632 million in 2011 and is projected to grow at a compound annual growth rate of 9.6 percent through 2016.
Read More

Hikma Pharmaceuticals to take over US generic injectables manufacturer

London-based multinational company Hikma Pharmaceuticals PLC has reached an asset acquisition agreement with Ben Venue Laboratories for the purchase of its U.S. generic injectables division, Bedford Laboratories, for $300 million.
Read More

EIA: Refineries unable to deal with increasing proportion of light crudes

Production of U.S. light crude oil and condensates is likely to continue dominating the domestic oil market, accounting for the majority of extra oil extracted over the next two years.
Read More